Entity

Time filter

Source Type

Jena, Germany

Inflarx Inc. | Entity website

InflaRx develops new first-in-class therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. InflaRx primary focus lies on the development of monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases


Inflarx Inc. | Entity website

InflaRx develops new first-in-class therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. InflaRx primary focus lies on the development of monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases


Inflarx Inc. | Entity website

InflaRx develops new first-in-class therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. InflaRx primary focus lies on the development of monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases


Inflarx Inc. | Entity website

InflaRx develops new first-in-class therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. InflaRx primary focus lies on the development of monoclonal antibodies targeting activation products of the complement system for application in life threatening inflammatory diseases

Discover hidden collaborations